Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geovax Labs (NQ: GOVX )

0.4400 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,209
Open 0.4400
Bid (Size) 0.4600 (139)
Ask (Size) 0.4656 (4)
Prev. Close 0.4400
Today's Range 0.4400 - 0.4400
52wk Range 0.4280 - 1.390
Shares Outstanding 26,695,287
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19

Performance

YTD
-29.97%
-29.97%
1 Month
-10.73%
-10.73%
3 Month
-24.14%
-24.14%
6 Month
-28.02%
-28.02%
1 Year
-43.41%
-43.41%

More News

Read More
Geovax Labs Earnings Preview
Via Benzinga
GeoVax to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 8, 2023
Via NewMediaWire
GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine
Via NewMediaWire
Exposures COVID-19
GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update
Via NewMediaWire
GeoVax to Participate in Upcoming November Investor and Industry Events
Via NewMediaWire
GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities
Via NewMediaWire
Topics Earnings Intellectual Property
Exposures COVID-19 Financial Intellectual Property
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
GeoVax Receives Notice of Allowance for Marburg Vaccine Patent
Via NewMediaWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property Product Safety
GeoVax Receives Notice of Allowance for HIV Vaccine Patent
Via NewMediaWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
GeoVax Labs And 3 Other Stocks Under $1 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
GeoVax to Participate in Upcoming October Investor and Industry Events
Via NewMediaWire
Exposures COVID-19
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX Suspension Cell Line to Bolster MVA-Based Vaccine Development
Via NewMediaWire
GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference
Via NewMediaWire
Exposures COVID-19
GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients
Via NewMediaWire
Exposures COVID-19
GeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment Conference
Via NewMediaWire
GeoVax Completes Enrollment of Phase 2 Trial for Next-Generation COVID-19 Vaccine Booster
Via NewMediaWire
Exposures COVID-19 Product Safety
GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Via NewMediaWire
GeoVax to Present at the Emerging Growth Conference on September 6, 2023
Via NewMediaWire
Exposures COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
GeoVax Receives Notice of Allowance for Malaria Vaccine Patent
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
ADDvantage Technologies Group And 3 Other Stocks Under $1 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
Via NewMediaWire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.